Search

everythinglearnresearchcommunity

for

Search:↓

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

A rare skin condition causes red and dark patches on the face and limbs.

17β-estradiol can reduce inflammation in the skin.

Euph E and Euri A from Euphorbia neriifolia help control inflammation and immune response in cells.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Corin helps control salt and sweat release in sweat glands.

Inhibiting EGFR weakens skin's defense against bacteria.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

EGF receptor is crucial for skin health and its inhibitors can cause skin rashes.

Repetin is a protein involved in skin and hair development, binding calcium and compensating for other proteins when needed.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Ber‐EP4 marks cells related to the secondary hair germ in hair follicles.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Fgfr2b helps maintain healthy skin and prevent cancer.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.